Skip to main content

Evoclin FDA Approval History

FDA Approved: Yes (First approved October 22, 2004)
Brand name: Evoclin
Generic name: clindamycin phosphate
Dosage form: Foam
Previous Name: Actiza
Company: Connetics Corporation
Treatment for: Acne

Evoclin (clindamycin) is a topical antibiotic indicated for the treatment of acne vulgaris.

Development timeline for Evoclin

Oct 22, 2004Approval Evoclin Connetics Corporation - Treatment for Acne
Mar  4, 2004Connetics' New Drug Application for Actiza Has Been Accepted For Filing by the FDA

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.